Purchase Order HHSN272201400815P
- Not listed
- This is a $13,020 firm-fixed-price purchase order contract awarded by the National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency, to the University of Massachusetts Medical School (UMMS) Grants and Contracts Administration Division. The contract is for AAV8 packaging for the PAVEGET project, which is being used for a mouse model gene therapy study. The contract does not have a set-aside designation. UMMS is a land grant university and public academic health sciences...
- This $16,060 firm fixed price purchase order contract was awarded by the National Human Genome Research Institute, a civilian agency, to the University of Massachusetts Medical School (UMMS) Grants and Contracts Administration Division. The contract, titled "MAXI PREP - ACADEMIC", has a completion date of June 3, 2025. UMMS is a public academic health sciences center engaged in a wide range of research and clinical activities. The contract does not have a set-aside designation. In...
- This is a Firm Fixed Price purchase order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences to the University of Massachusetts Medical School (UMass Medical) for $19,652.00. The contract is for D2/D3 ex-vivo receptor occupancy studies in Sprague Dawley rats, with a period of performance from June 7, 2021 to August 6, 2021. The place of performance is in Worcester, Massachusetts. There...
- This federal contract award was made by the Bureau of Medicine and Surgery, a Defense agency, to the University of Massachusetts Medical School (UMass Medical) to provide tuition and fees. The $120,402.00 firm fixed price delivery order contract has an ultimate completion date of December 31, 2024. UMass Medical has significant experience providing comprehensive medical services to the Department of Justice Bureau of Prisons, including outside hospital care, kidney transplant procedures, and...
- The University of Massachusetts Medical School Grants and Contracts Administration Division (doing business as Umms) was awarded a $16,060 purchase order by the National Institutes of Health's National Human Genome Research Institute to provide adenovirus-associated virus preparations in support of academic research. As the prime contractor, Umms will deliver the requested biological products for use at its Worcester, Massachusetts location under a firm fixed price contract running from August...
- This is a $6,325,163.04 definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to the University of Massachusetts Medical School (UMMS) for a project titled "LARGE SCALE T CELL EPITOPE DISCOVERY". The contract does not have a set-aside designation. The objective is to conduct research to identify T-cell epitopes of pathogenic fungi including Blastomyces, Coccidioides, Cryptococcus, and...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $5.82M cost-reimbursement definitive contract to the University of Massachusetts Medical School (UMMS) on September 30, 2024, for research on CD4 and CD8 T cell epitopes recognized in autoimmune and autoinflammatory diseases. The contract, which extends through September 29, 2029, supports multi-disciplinary research teams engaged in large-scale discovery and validation of T cell immune epitopes associated with...
- This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health (NIH), to the University of Maryland, Baltimore (UMB) as the prime contractor. The $2,752,906.46 contract is for Vaccine Treatment and Evaluation Units (VTEU), a major NIAID program that supports clinical trials and medical research on vaccines and treatments for infectious diseases. The contract is a delivery order under the larger VTEU...
- This is a $358,696 delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to the University of Maryland, Baltimore (UMB) under the Vaccine and Treatment Evaluation Units (VTEU) Indefinite Delivery Vehicle (IDV). The order supports a base award for HHSN272201300022I, with a total ceiling value of $1,033,104.95 and an ultimate completion date of July 11, 2023. The award does not have...
- This is a $114,051.00 delivery order contract awarded by the Department of the Navy to the University of Massachusetts Medical School (UMass Medical) on January 2, 2025. The contract is for tuition and fees and has a period of performance through June 30, 2025. It is a firm fixed price contract and does not utilize a set-aside designation. UMass Medical is an academic medical center that has a robust track record of receiving federal contract and grant awards from agencies such as the National...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health (NIH), to the University of Massachusetts Medical School (UMass Medical) for the purchase of a 7 mg vial of the CD3 immunotoxin PR-0307 at a firm fixed price of $7,000.00. The award has no set-aside designation and was made as a purchase order on August 5, 2014, with a completion date of September 3, 2014. UMass Medical, which operates as a division of the overall University of Massachusetts system, has extensive experience conducting biomedical research and providing medical services to federal agencies, including the Department of Justice Bureau of Prisons, through both contracts and grants. This contract award appears to be a discrete purchase of a specialized immunotoxin reagent to support NIAID's research activities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| 1 | Funding Only Action | ($100) | 5/9/15 | |
| Not listed | Not listed | $7.1k | 8/6/14 |